JENNIFER BROWN: Open Payments
NPI 1528776861 · EASTMAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 7 payments from 4 companies in 2025. Trend: 2023 $105 · 2024 $46 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Lilly USA, LLC | 4 | $75 |
| Organogenesis Inc. | 1 | $50 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
Products named: INGREZZA, MOUNJARO, APLIGRAF, GEMTESA, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
